News

Sustainability in lateral flow testing is broader than material substitution. This article explores how material design, reagent strategy, manufacturing yield, performance testing, supply chain choices and at-source testing can reduce waste across the full lateral flow test lifecycle.

Performance verification is the stage at which a lateral flow assay moves from development understanding to formal analytical evidence. This article explains how intended use and design inputs shape verification strategy, how CLSI-guided studies are structured, and why robust documentation is critical for transfer, submission, and product readiness.

Lateral Flow Assays (LFAs) may look simple, but successful development is far from straightforward. Behind reliable, consistent performance lies careful control of multiple interacting variables that can otherwise introduce hidden risk. Too often, development challenges surface late, when changes are costly, timelines slip and verification efforts fail. The difference between a smooth path to market and repeated re-design frequently comes down to early technical decisions and

We are excited to announce that Fleet Bioprocessing Ltd. are launching a new service: from today we will be offering contract development of lateral flow devices (LFDs) to our customers. LFDs form a cornerstone of modern diagnostics, providing a rapid means to detect diseases in a point-of-care (POC) format that can be used in people’s own homes or in primary care, with broader applications spanning clinical, veterinary, industrial and environmental settings. Traditionally LF